We’re excited to share that Colorcon was highlighted in The Pharma Navigator during CPHI Frankfurt 2025, the world’s leading pharmaceutical event held October 28–30 at Messe Frankfurt. This feature underscores our commitment to driving innovation in oral solid dosage (OSD) forms and supporting the pharmaceutical industry with advanced solutions.
What the Article Covered
In the interview, Shahrzad Missaghi, Director of Strategic Technical Solutions and Business Development at Colorcon, discussed the key trends shaping the future of OSDs:
- Oral Delivery of Biologics: Innovative platforms, including ingestible devices, are opening new possibilities for patient-friendly delivery of complex therapeutics.
- Enhanced Solubility and Bioavailability: Novel technologies continue to address challenges with poorly soluble drugs.
- Sustainable Manufacturing: Emphasis on reducing environmental impact through greener processes.
- Digitalization and AI: Adoption of data-driven approaches for formulation development and clinical trials, including tools like Colorcon’s HyperStart® C2C platform for streamlined OSD development.
These advancements aim to accelerate drug development while ensuring manufacturability, scalability, and patient acceptability.
Our Presence at CPHI Frankfurt
At our booth, visitors explored Colorcon’s comprehensive portfolio—from film coating systems and core excipients to controlled release technologies and functional packaging solutions. Our interactive stand featured tablet samples, packaging displays, and digital brochures, creating an engaging experience that reflected our brand identity and innovation leadership.
Read the Full Article
